A patient is diagnosed with an ST-elevation myocardial infarction (STEMI) and has elevated troponin levels. The nurse prepares the patient for potential percutaneous coronary intervention (PCI). Which nursing intervention is most important to prioritize for this patient before the procedure?

B) Initiate continuous cardiac monitoring to detect any arrhythmias.

A) Educate the patient about lifestyle changes to manage hypertension.

B) Initiate continuous cardiac monitoring to detect any arrhythmias.

C) Administer statin medication to manage hyperlipidemia.

D) Provide a low-fat diet to reduce cardiac workload.

A patient diagnosed with an acute ST-elevation myocardial infarction (STEMI) is being prepared for percutaneous coronary intervention (PCI). Given the diagnostic findings, which of the following nursing interventions is the highest priority to prevent further myocardial damage?

C) Initiate anticoagulant therapy as prescribed

A) Administer oxygen to maintain adequate saturation

B) Monitor and document cardiac rhythm continuously

C) Initiate anticoagulant therapy as prescribed

D) Educate the patient about lifestyle modifications post-discharge

A patient post-PCI for acute STEMI is experiencing frequent PVCs and runs of non-sustained ventricular tachycardia. The blood pressure is elevated at 180/100 mmHg, and the heart rate is 110 beats per minute. Intravenous amiodarone and an ACE inhibitor have been initiated. What is the priority nursing intervention to monitor the effectiveness of this treatment?

C) Continuously monitor cardiac rhythm and blood pressure.

A) Monitor the patient's blood glucose levels.

B) Assess the patient's neurological status frequently.

C) Continuously monitor cardiac rhythm and blood pressure.

D) Check the patient's peripheral pulses every hour.

A patient with a recent STEMI and successful PCI is now in the coronary care unit. Despite stabilization, the patient exhibits a rise in blood pressure and heart rate, frequent PVCs, and runs of non-sustained ventricular tachycardia. Which of the following interventions should the nurse prioritize to address these complications and prevent further cardiac events?

A) Administer a beta-blocker to decrease myocardial oxygen demand.

B) Increase the dose of the intravenous amiodarone to control arrhythmias.

C) Administer a diuretic to reduce potential volume overload.

D) Encourage the patient to ambulate to improve circulation.

A patient with a history of hypertension and arrhythmia develops acute decompensated heart failure. Intravenous furosemide is administered to manage fluid overload. Which of the following assessment findings is most crucial for the nurse to monitor to prevent complications associated with diuretic therapy?

B) Serum potassium level of 3.0 mEq/L

A) Blood pressure of 135/85 mmHg

B) Serum potassium level of 3.0 mEq/L

C) Heart rate of 78 beats per minute

D) Respiratory rate of 20 breaths per minute

A patient with heart failure was treated with intravenous furosemide. Twelve hours later, they presented with muscle cramps, weakness, and hypokalemia. Which of the following interventions should the nurse prioritize to address the underlying cause of these symptoms?

A) Administer an oral potassium supplement

B) Increase the dose of furosemide

D) Encourage bed rest and fluid restriction

A patient with heart failure has been receiving intravenous furosemide for fluid overload. Twelve hours post-administration, the patient exhibits muscle cramps and weakness, and lab results show a serum potassium level of 3.1 mEq/L. Which of the following actions should the nurse prioritize to address these findings?

B) Administer oral potassium supplements as prescribed.

A) Increase the dose of furosemide to enhance diuresis.

B) Administer oral potassium supplements as prescribed.

C) Restrict the patient's fluid intake to prevent further overload.

D) Continue monitoring without any changes, as these symptoms are expected.

A patient with a history of acute coronary syndrome is experiencing new-onset chest discomfort and mild shortness of breath 24 hours after intervention for hypokalemia. The ECG shows ST-segment depression, and troponin levels have increased. What is the most appropriate immediate nursing action?

C) Administer sublingual nitroglycerin to relieve ischemic chest pain.

A) Administer a dose of intravenous potassium to address potential hypokalemia.

B) Prepare the patient for possible revascularization procedures.

C) Administer sublingual nitroglycerin to relieve ischemic chest pain.

D) Increase the patient's oxygen flow rate to improve oxygenation.

A patient with a history of acute coronary syndrome presents with new-onset chest discomfort and mild shortness of breath. The nurse notes elevated heart rate and blood pressure, diaphoresis, and restlessness. The ECG shows ST-segment depression, and troponin levels are mildly elevated. Considering these findings, which nursing intervention should take priority to address the patient's current condition?

A) Administer a prescribed sublingual nitroglycerin tablet.

B) Increase the patient's oxygen flow rate to 6L via nasal cannula.

C) Notify the physician for potential revascularization procedures.

D) Educate the patient about lifestyle modifications to prevent future cardiac events.

acute coronary syndrome - Nursing Case Study

Pathophysiology

• Primary mechanism: Rupture of an atherosclerotic plaque in a coronary artery triggers platelet aggregation and thrombus formation, leading to partial or complete blockage of blood flow to the heart muscle.

• Secondary mechanism: Reduced oxygen supply due to the blockage causes myocardial ischemia, resulting in chest pain, and if prolonged, can lead to myocardial cell death (infarction).

• Key complication: The imbalance between oxygen supply and demand can lead to electrical instability in the heart, increasing the risk of arrhythmias, which are potentially life-threatening.

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Key past medical history: Hypertension, hyperlipidemia, smoking (20 pack-years)

• Current medications: Lisinopril 10 mg daily, Atorvastatin 20 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe chest pain radiating to the left arm

• Key symptoms: Shortness of breath, sweating, nausea, dizziness

• Vital signs: Blood pressure 145/90 mmHg, Heart rate 110 bpm, Respiratory rate 24 breaths per minute, Temperature 37.4°C, Oxygen saturation 92% on room air

Section 1

New Diagnostic Results:

Following the initial assessment, the patient was promptly sent for an electrocardiogram (ECG) and blood tests, including cardiac biomarkers to evaluate the extent of myocardial injury. The ECG revealed ST-segment elevation indicative of an acute ST-elevation myocardial infarction (STEMI). This finding suggests a complete blockage of the coronary artery, necessitating immediate intervention to restore blood flow and minimize heart muscle damage. Concurrently, laboratory results showed elevated troponin levels, confirming myocardial injury. The ECG also demonstrated occasional premature ventricular contractions, raising concerns about potential arrhythmias.

A chest X-ray was also performed to assess for any additional complicating factors such as pulmonary edema or cardiomegaly, given the patient's shortness of breath and history of hypertension. The X-ray did not show signs of fluid overload, but mild cardiomegaly was noted, which aligns with his history of hypertension and potential chronic cardiac remodeling. These results emphasize the need for rapid reperfusion therapy, such as percutaneous coronary intervention (PCI), to address the acute blockage and prevent further complications. The findings also highlight the necessity for close monitoring of cardiac rhythm to manage the risk of arrhythmias effectively.

These diagnostic outcomes underscore the critical nature of the patient’s condition and the urgency of intervention. They provide a clearer picture of the underlying pathology and help guide the clinical team in tailoring the management plan, including the initiation of anticoagulant therapy and adjusting current medications to manage his hypertension and hyperlipidemia more effectively. The next steps will involve preparing the patient for potential PCI and ensuring hemodynamic stability while addressing any emerging complications from the myocardial infarction.

Section 2

Following the confirmation of an acute STEMI, the patient was swiftly transferred to the cardiac catheterization lab for percutaneous coronary intervention (PCI). During the procedure, angiography revealed a 100% occlusion of the left anterior descending artery. The interventional cardiologist successfully performed balloon angioplasty and placed a drug-eluting stent, restoring blood flow. Post-procedure, the patient was transferred to the coronary care unit for close monitoring.

In the hours following the intervention, the patient's condition initially stabilized, with a significant reduction in chest pain and normalization of ST-segment elevation on subsequent ECGs. However, vital signs indicated a new development: the blood pressure rose to 180/100 mmHg despite ongoing antihypertensive therapy, and the heart rate increased to 110 beats per minute. These changes hinted at potential complications such as heightened sympathetic activity or volume overload due to impaired myocardial function.

Shortly thereafter, the patient began experiencing frequent premature ventricular contractions (PVCs) and occasional runs of non-sustained ventricular tachycardia, as detected on continuous telemetry monitoring. These arrhythmias, coupled with elevated blood pressure, raised concerns of increased myocardial oxygen demand and potential for further cardiac events. The clinical team promptly initiated intravenous amiodarone to manage the arrhythmias and adjusted the antihypertensive regimen, including the addition of an ACE inhibitor to promote cardiac remodeling and control blood pressure. This approach required careful balance to prevent hypotension while ensuring optimal cardiac output, emphasizing the need for vigilant monitoring and timely adjustments to the management plan.

Section 3

As the clinical team continued to manage the patient's arrhythmias and hypertension, they observed a change in the patient's status that necessitated further investigation. Approximately six hours after the intervention, the patient reported increased shortness of breath and a feeling of lightheadedness. A repeat physical assessment revealed bilateral crackles in the lung bases, suggesting fluid accumulation. The patient's oxygen saturation had dropped to 90% on room air, indicating compromised oxygenation. These findings prompted the clinical team to suspect the development of acute heart failure, possibly due to myocardial stunning or an increase in left ventricular filling pressures.

To confirm the suspected diagnosis and guide further management, the team ordered a chest X-ray and a B-type natriuretic peptide (BNP) level. The chest X-ray showed pulmonary congestion consistent with heart failure, and the BNP level was elevated at 1200 pg/mL, further supporting the diagnosis of acute decompensated heart failure. This development required an adjustment of the treatment plan, focusing on diuresis and optimizing cardiac function. Intravenous furosemide was administered to reduce fluid overload and improve respiratory status, while the team closely monitored the patient's renal function and electrolyte levels to prevent complications associated with diuretic therapy.

The patient's response to these interventions was crucial in determining the next steps in their care. Over the following hours, the patient's respiratory status improved, with a gradual increase in oxygen saturation to 95% on supplemental oxygen. The crackles diminished, and the patient reported a reduction in dyspnea. Despite these improvements, the clinical team remained vigilant for potential complications such as electrolyte imbalances or worsening renal function. Continuous reassessment and timely adjustments to the care plan were essential to ensure the patient’s stabilization and recovery from this episode of acute decompensated heart failure.

Section 4

As the clinical team continued to monitor the patient's progress, they observed a promising initial response to the diuretic therapy. However, new complications soon emerged, requiring further clinical reasoning and adjustment of the treatment plan. Approximately twelve hours after the administration of intravenous furosemide, the patient began exhibiting signs suggestive of electrolyte imbalances. The patient reported experiencing muscle cramps and generalized weakness. A review of the recent laboratory results revealed a serum potassium level of 3.1 mEq/L, indicating hypokalemia, a known complication of aggressive diuresis. Additionally, the patient's serum creatinine level had increased from 1.1 mg/dL to 1.5 mg/dL, raising concerns about renal function impairment.

Recognizing the risk of further complications from these imbalances, the clinical team promptly initiated potassium supplementation to address the hypokalemia and adjusted the diuretic regimen to minimize further renal strain. The patient's fluid status was reassessed, and a decision was made to reduce the dose of furosemide while maintaining close monitoring of urine output and renal function. To support renal perfusion, the team ensured that the patient's blood pressure was adequately managed, aiming for a balance that would optimize cardiac output without exacerbating the heart failure.

The team's proactive approach and timely interventions were crucial in stabilizing the patient's condition. As the electrolyte levels normalized, the patient’s muscle cramps and weakness subsided. Renal function showed signs of improvement, with creatinine levels gradually decreasing. This episode highlighted the importance of vigilant monitoring and the need for dynamic adjustments in the management plan to prevent and address complications promptly. With the patient's condition stabilizing, the clinical team prepared to transition the patient to a maintenance regimen, focusing on long-term management strategies to prevent future episodes of acute decompensated heart failure.

Section 5

As the clinical team continued to monitor the patient's progress, they noted that the patient's overall condition was stabilizing, with improving renal function and normalized electrolyte levels. However, approximately 24 hours after the initial intervention for hypokalemia, the patient reported experiencing new-onset chest discomfort and mild shortness of breath. The nurse on duty conducted a thorough assessment, noting that the patient appeared slightly diaphoretic and restless, with an elevated heart rate of 110 beats per minute and blood pressure reading of 140/85 mmHg. Given the patient's recent history of acute coronary syndrome, these findings raised concerns about potential myocardial ischemia or another cardiac event.

To further evaluate the situation, the clinical team ordered an urgent electrocardiogram (ECG) and cardiac enzyme tests. The ECG revealed ST-segment depressions in the anterior leads, suggesting possible ischemia, while the cardiac enzyme levels, including troponin I, were mildly elevated at 0.08 ng/mL, up from a baseline of 0.02 ng/mL. These results indicated that the patient might be experiencing a new ischemic episode, necessitating immediate intervention to prevent further cardiac compromise. The team promptly initiated anti-ischemic therapy, including the administration of sublingual nitroglycerin and adjustments to the patient's beta-blocker dosage to achieve optimal heart rate control.

The emergence of these new symptoms and diagnostic findings highlighted the complexity of managing acute coronary syndrome, especially in the context of recent diuretic therapy and electrolyte imbalances. The clinical team engaged in a collaborative discussion to re-evaluate the patient's overall management plan, considering the need for potential revascularization procedures and the optimization of pharmacologic therapy. This situation underscored the importance of continuous monitoring and dynamic clinical reasoning to adapt to evolving clinical scenarios, ensuring that the patient's care plan remained responsive to both current needs and potential future challenges.